Forget those old sci-fi films where you’d need a massive helmet and a lab full of wires to move a cursor with your mind; the future of your iPhone is getting a lot more intimate.
Last year, Apple teamed up with the brain-computer interface experts at Synchron to bridge the gap between your thoughts and your touch-screen. This partnership was a massive deal because it moves away from the “cool” factor of new gadgets and focuses on a much more grounded goal: giving people with limited mobility the power to text, email, and scroll just by thinking about it. Now, the actual technology is getting closer than ever.
While the idea of your iPad being tuned into your brainwaves might sound a bit rattling at first, the technology is actually about translating specific motor intentions into digital commands without you having to lift a finger. Before you start worrying that your phone is going to start blabbing your secret thoughts to your contacts, it’s worth looking at how this bit of kit actually sits inside the body and what it really means for the next generation of Apple gear.
What the technology actually is
Synchron makes an implantable device called the Stentrode, a stent-like device that sits in a vein directly above the brain’s motor cortex and reads electrical brain signals. Those signals are then translated into actions on screen, allowing a user to navigate interfaces and select icons without any physical movement or voice commands.
The device is implanted without open brain surgery, which distinguishes it from some competing approaches and makes it a more viable option for people with conditions that limit their ability to undergo complex procedures. Apple’s role in the partnership is to build the software and device integration that allows those translated brain signals to interact natively with its operating systems.
There’s someone who’s already using it.
Mark Jackson, a Pittsburgh resident living with ALS, has had the Stentrode implanted and has been testing the Apple integration as part of the early development programme. His experience illustrates both the genuine promise of the technology and the significant limitations that still exist at this stage. Using Apple Vision Pro while connected to the Stentrode, Jackson was able to experience a virtual environment overlooking the Swiss Alps in a way that felt physically real, despite his limited motor function preventing him from standing.
At the same time, he’s been straightforward about what the technology can’t yet do, noting that it can’t replicate the speed and precision of a mouse cursor or a touchscreen, meaning navigation is considerably slower than conventional interaction with a phone or computer. That honesty from early testers is useful context for understanding where this sits on the development curve.
What Synchron claims to have achieved
Synchron says it is the first brain-computer interface company to achieve native integration with a new BCI Human Interface Device profile, which in practical terms means the Stentrode can communicate directly with Apple’s operating systems in a standardised way rather than through a workaround.
That kind of native integration matters because it means the technology can work across Apple’s ecosystem of devices rather than being limited to a single application or platform, and it creates a foundation that can be built on as the technology develops.
How this sits alongside Neuralink
Apple and Synchron aren’t operating in a vacuum. Elon Musk’s Neuralink has been developing neurotechnology with similar capabilities, and its N1 chip was implanted in a human for the first time in early 2024. Musk reported that the person was subsequently able to control a cursor using their thoughts. The two approaches differ in their implantation methods and their stated aims, with Neuralink pursuing broader applications and Synchron focusing on its less invasive surgical approach, but both are working toward the same fundamental goal of giving people direct brain-to-device control.
Apple partnering with Synchron rather than developing its own BCI hardware is consistent with how the company typically approaches emerging technology categories, working with specialists while providing the software infrastructure and ecosystem integration.
The accessibility context is important.
It would be easy to frame this as a futuristic technology story and miss the more immediate and significant point, which is that for people with conditions like ALS, locked-in syndrome, or severe spinal cord injuries, the ability to control a phone or computer independently is not a novelty but a meaningful restoration of autonomy.
Apple has been investing in accessibility technology more broadly across this period, including Personal Voice, a feature that allows people who are losing the ability to speak to create a synthesised version of their own voice, which is being upgraded in the upcoming iOS 19 release. Eye and head tracking tools are also being improved for faster and more accurate typing.
The brain-computer interface work sits within this broader direction rather than being separate from it, and understanding it as an accessibility development rather than primarily a consumer technology story gives it its proper weight.
What comes next
The partnership is at an early stage and the testing pool is currently small, which means there’s a significant distance between what’s been demonstrated and a product that could be widely available. The technology will need to prove itself across a larger and more diverse group of users, the navigation speed limitations Jackson described will need to be substantially improved for the experience to feel genuinely useful rather than merely possible, and the regulatory landscape around implantable medical devices adds a layer of complexity to any timeline.
None of that diminishes what’s already been achieved, but it does mean that expectations about how quickly this will become a practical tool for the broader disability community need to be calibrated carefully. The direction is clear, and the early results are encouraging. The distance still to travel is considerable.
